Drug Interaction Report

Avapritinib and Telotristat Ethyl: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Telotristat Ethyl

Xermelo
+

Avapritinib

Ayvakit Ayvakit®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 126 documented Avapritinib interactions, 108 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
probable
Severity
Major

What happens

Reduced avapritinib exposure and reduced efficacy of avapritinib

Interaction Deep Dive

Avoid coadministration of avapritinib with strong or moderate CYP3A inducers. Coadministration of avapritinib with a strong or moderate CYP3A inducer may reduce avapritinib exposure, which may reduce efficacy of avapritinib1.

Why it happens (mechanism)

Induction of CYP3A-mediated metabolism of avapritinib

Literature reports

2 reports — tap to read

a) Coadministration of avapritinib 400 mg as a single dose with rifAMPin 600 mg once daily (a strong CYP3A inducer) decreased avapritinib Cmax by 74% and AUC by 92% 1.

b) Coadministration of avapritinib 300 mg once daily with efavirenz 600 mg once daily (a moderate CYP3A inducer) is predicted to decrease avapritinib Cmax by 55% and AUC by 62% at steady-state 1.

Common questions

Can I take Avapritinib and Telotristat Ethyl together?

Reduced avapritinib exposure and reduced efficacy of avapritinib Always confirm with your pharmacist or prescriber before making any change.

How serious is the Avapritinib and Telotristat Ethyl interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Avapritinib or Telotristat Ethyl need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: AYVAKIT(TM) oral tablets, avapritinib oral tablets. Blueprint Medicines Corporation (per manufacturer), Cambridge, MA, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.